Healthy Volunteers

98 competing products in clinical development for Healthy Volunteers.

Pipeline by Phase

Pre-clinical1

Phase 196

Approved1

All Products (98)

Product	Company	Stage	Status	Hype
ASP5502 + Placebo	Astellas Pharma	Phase 1	Recruiting	36
E2086	Eisai	Phase 1	Recruiting	36
Placebo + KK4277	Kyowa Kirin	Phase 1	Active	33
MORF-057 + Placebo for MORF-057	Eli Lilly	Phase 1	Completed	29
LY2157299	Eli Lilly	Phase 1	Completed	29
LY3015014 + Placebo	Eli Lilly	Phase 1	Completed	29
Evacetrapib + Digoxin	Eli Lilly	Phase 1	Completed	29
Evacetrapib + Pravastatin	Eli Lilly	Phase 1	Completed	29
LOXO-305 + Omeprazole	Eli Lilly	Phase 1	Completed	29
Insulin Peglispro	Eli Lilly	Phase 1	Completed	29
LY2605541	Eli Lilly	Phase 1	Completed	29
LY2969822 + Placebo	Eli Lilly	Phase 1	Completed	29
LY3045697 + Placebo + Spironolactone + Placebo	Eli Lilly	Phase 1	Completed	29
Trastuzumab	Celltrion	Phase 1	Completed	29
PCO371 + [14C]PCO371 + [14C]PCO371	Chugai Pharmaceutical	Phase 1	Completed	29
GYM329 + Placebo	Chugai Pharmaceutical	Phase 1	Completed	29
YHP1906 + YHR1902	Yuhan	Phase 1	Completed	29
YHP2205 + YHR2401	Yuhan	Phase 1	Completed	29
YHP2205 + YHR2401	Yuhan	Phase 1	Completed	29
YHR2402 + YHR2402+YHR2403	Yuhan	Phase 1	Completed	29
YHP2305 + YHR2404	Yuhan	Phase 1	Completed	29
Prasugrel ODT1 - Tablet + Prasugrel ODT2 - Tablet + Prasugrel ODT2 - Suspension	Daiichi Sankyo	Phase 1	Completed	29
Treatment A - 400 mg Fasting + Treatment B - 400 mg Fed + Treatment C - 200 mg Fed	Daiichi Sankyo	Phase 1	Completed	29
ASP1617 + Placebo	Astellas Pharma	Phase 1	Completed	29
fezolinetant	Astellas Pharma	Phase 1	Completed	29
fezolinetant - test formulation + fezolinetant - reference formulation	Astellas Pharma	Phase 1	Completed	29
ASP6858 + Placebo	Astellas Pharma	Phase 1	Completed	29
14C-labeled ASP0367	Astellas Pharma	Phase 1	Completed	29
ASP8062 + Alcohol + ASP8062 Placebo + Alcohol Placebo	Astellas Pharma	Phase 1	Completed	29
MA-0211 + Placebo	Astellas Pharma	Phase 1	Completed	29
pudexacianinium chloride	Astellas Pharma	Phase 1	Completed	29
ASP1517 + Kremezin®	Astellas Pharma	Phase 1	Completed	29
mirabegron + Bisoprolol + propranolol + placebo	Astellas Pharma	Phase 1	Completed	29
ASP8825	Astellas Pharma	Phase 1	Completed	29
peficitinib	Astellas Pharma	Phase 1	Completed	29
ASP1941 + Miglitol	Astellas Pharma	Phase 1	Completed	29
ASP1941 + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP1517 + Placebo	Astellas Pharma	Phase 1	Completed	29
solifenacin succinate + mirabegron	Astellas Pharma	Phase 1	Completed	29
Pudexacianinium chloride + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP8062 + Placebo	Astellas Pharma	Phase 1	Completed	29
Mirabegron + Minidril + Placebo	Astellas Pharma	Phase 1	Completed	29
fezolinetant	Astellas Pharma	Phase 1	Completed	29
ASP3700 + itraconazole + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP6282 + Itraconazole + Pilocarpine + Placebo + Midazolam	Astellas Pharma	Phase 1	Completed	29
ASP7713 + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP7962 + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP1128 + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP015K + Placebo	Astellas Pharma	Phase 1	Completed	29
Regadenoson + Placebo	Astellas Pharma	Phase 1	Completed	29
peficitinib	Astellas Pharma	Phase 1	Completed	29
Mirabegron	Astellas Pharma	Phase 1	Completed	29
Midazolam + Cefiderocol	Shionogi	Phase 1	Completed	29
S-337395 + Placebo	Shionogi	Phase 1	Completed	29
E6007 + E6007 matching placebo	Eisai	Phase 1	Completed	29
E2730 + E2730-matched placebo	Eisai	Phase 1	Completed	29
Avatrombopag maleate 40 mg	Eisai	Phase 1	Completed	29
E8001 + Placebo	Eisai	Phase 1	Completed	29
EA1080 + EA1080 + EA1080 + EA1080 + EA1080-matching placebo + EA1080 + EA1080	Eisai	Phase 1	Completed	29
E7386 Tablet + (14C)E7386 Capsule + (14C)E7386	Eisai	Phase 1	Completed	29
E2025 + Placebo	Eisai	Phase 1	Completed	29
Lenvatinib	Eisai	Phase 1	Completed	29
Lemborexant	Eisai	Phase 1	Completed	29
Aducanumab	Eisai	Phase 1	Completed	29
Lenvatinib 10 mg	Eisai	Phase 1	Completed	29
E2086 + Placebo	Eisai	Phase 1	Completed	29
ketoconazole-placebo + placebo-ketoconazole	Eisai	Phase 1	Completed	29
Lecanemab + Lecanemab	Eisai	Phase 1	Completed	29
E2511 + Placebo	Eisai	Phase 1	Completed	29
E2006 2.5 mg + E2006 10 mg + E2006 25 mg + Placebo	Eisai	Phase 1	Completed	29
[14C]E7090	Eisai	Phase 1	Completed	29
E6742 + Placebo	Eisai	Phase 1	Completed	29
Lecanemab + Lecanemab	Eisai	Phase 1	Completed	29
E2511 + E2511 Matched Placebo	Eisai	Phase 1	Completed	29
Dotinurad	Eisai	Phase 1	Completed	29
E2814 + E2814-matched placebo	Eisai	Phase 1	Completed	29
E2086 + Placebo	Eisai	Phase 1	Completed	29
Sancuso - Part 1 + Sancuso - Part 2	Kyowa Kirin	Phase 1	Completed	29
FOY-305	Ono Pharmaceutical	Phase 1	Completed	29
ONO-4685 + Placebo + KLH + KLH, ONO-4685 + KLH, placebo	Ono Pharmaceutical	Phase 1	Completed	29
ONO-2020 + Placebo	Ono Pharmaceutical	Phase 1	Completed	29
ONO-2910 + Placebo + ONO-2910 + Placebo	Ono Pharmaceutical	Phase 1	Completed	29
eperisone hydrochloride plus diclofenac sodium capsule + eperisone hydrochloride tablet and diclofenac sodium tablet	Eisai	Pre-clinical	Completed	26
KPL-404	Kiniksa Pharmaceuticals	Phase 1	Completed	23
Sacubitril and Valsartan Sodium Tablets 24 mg/26 mg + Entresto 50 mg	Dr. Reddy's Laboratories	Phase 1	UNKNOWN	22
ASP2713 + placebo	Astellas Pharma	Phase 1	Withdrawn	21
ASP3700 + Placebo	Astellas Pharma	Phase 1	Withdrawn	21
E7386	Eisai	Phase 1	Withdrawn	21
Placebo + KHK4951	Kyowa Kirin	Phase 1	Terminated	21
ZN-d5	Zentalis Pharmaceuticals	Phase 1	Completed	19
Forteo	Rani Therapeutics	Phase 1	Completed	19
Stelara	Rani Therapeutics	Phase 1	Completed	19
ATH-1105 + Placebo	LeonaBio	Phase 1	Completed	19
[14C]-Fosgonimeton	LeonaBio	Phase 1	Completed	19
ATH-1020 + Placebo	LeonaBio	Phase 1	Completed	19
simufilam	Cassava Sciences	Phase 1	Completed	19
mRNA-6231	Moderna	Phase 1	Completed	0
mRNA-1273.712	Moderna	Approved	Completed	0